日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Frailty Assessment for Risk prediction in Gynecologic Oncology patients undergoing surgery and chemotherapy (FARGO) study protocol: Rationale and design of a multi-centre prospective cohort study

妇科肿瘤患者手术和化疗风险预测的衰弱评估(FARGO)研究方案:一项多中心前瞻性队列研究的原理和设计

Nguyen, Julie My Van; Vicus, Danielle; Hogen, Liat; Zigras, Tiffany; Paré, Guillaume; Chong, Michael; Benitez, Yetiani Roldan; Devereaux, P J; Ofori, Sandra; Borges, Flavia K; Di Sante, Emily; Miletic, Denise; Panus, Olivia; Vincent, Jessica; Ramasundarahettige, Chinthanie; Nene, Sofia; Patel, Ameen; Marcucci, Maura

Arthroscopic Assisted Surgical Technique of Impaction Bone Grafting and Autologous Matrix-Induced Chondrogenesis for Deep Osteochondral Knee Defects

关节镜辅助下骨移植联合自体基质诱导软骨形成术治疗深部膝关节骨软骨缺损

Turan, Kaya; Zigras, Filippos; Mitrousias, Vasileios; Hantes, Michael

Dual-mobility thumb carpometacarpal joint arthroplasty. Keypoints of surgical procedure for a satisfying outcome

双活动拇指腕掌关节成形术。手术操作要点,以获得满意的手术效果

Athanaselis, Efstratios D; Zigras, Filippos; Karachalios, Theofilos; Varitimidis, Sokratis

Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations

加拿大关于人乳头瘤病毒检测阳性结果管理的指南及针对特定人群的指导

Zigras, Tiffany; Mayrand, Marie-Hélène; Bouchard, Celine; Salvador, Shannon; Eiriksson, Lua; Almadin, Chelsea; Kean, Sarah; Dean, Erin; Malhotra, Unjali; Todd, Nicole; Fontaine, Daniel; Bentley, James

Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review

贝伐珠单抗治疗低级别浆液性卵巢癌:系统评价

Lazurko, Caitlin; Linder, Revital; Pulman, Kate; Lennox, Genevieve; Feigenberg, Tomer; Fazelzad, Rouhi; May, Taymaa; Zigras, Tiffany

Innovations in the Management of Vaginal Cancer

阴道癌治疗的创新

Kulkarni, Anjali; Dogra, Nupur; Zigras, Tiffany

Sarcopenic Dysphagia. A Narrative Review

肌少症性吞咽困难:叙述性综述

Dellis, Spilios; Papadopoulou, Soultana; Krikonis, Konstantinos; Zigras, Filippos

Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro

达克替尼 (PF-00299804) 是一种第二代不可逆泛 erbB 受体酪氨酸激酶抑制剂,体外对 HER2 扩增的子宫浆液性子宫内膜癌表现出显著的活性

Liancheng Zhu, Salvatore Lopez, Stefania Bellone, Jonathan Black, Emiliano Cocco, Tiffany Zigras, Federica Predolini, Elena Bonazzoli, Beatrice Bussi, Zachary Stuhmer, Carlton L Schwab, Diana P English, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E Schwartz, Thomas J Rutherford, Alessandro D